Skip to search formSkip to main contentSkip to account menu

BXL 0124

Known as: BXL-0124, BXL0124 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Abstract 276: Targeting cancer stem cells with chemopreventive agents for breast cancer prevention
Breast cancer accounts for one of the most common causes of cancer-related deaths in women. Despite the available treatment… 
2017
2017
Studiedag JWW BXL: een sterk netwerk: resultaten, reflecties en toekomst
2014
2014
Abstract 1236: A gemini vitamin D analogue, BXL0124, represses mammosphere formation and decreases expression of stem cell markers in MCF10DCIS breast cancer cells
Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA It has been suggested that cancer stem cells (CSCs), which… 
2013
2013
The repression of CD44-STAT3 signaling by BXL0124 in basal-like breast cancer cells.
2013
2013
Abstract 180: Inhibition of tumorigenesis by a novel Gemini vitamin D analog BXL0124 and a synthetic triterpenoid CDDO-Im in MMTV-HER2/neu transgenic mice.
Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC HER2 amplification is one of major genetic… 
2013
2013
Abstract 184: A gemini vVitamin D analog, BXL0124, inhibits mammary tumorigenesis by delaying the transition of ductal carcinoma in situ to iInvasive breast carcinoma.
The transition of ductal carcinoma in situ (DCIS) to invasive carcinoma is a crucial event in the progression of breast tumors… 
2012
2012
Abstract CN08-04: Novel Gemini vitamin D compounds for prevention of breast cancer by targeting stem cells
Identification and characterization of cancer stem cells in cancer development offers a new promising strategy in cancer… 
2012
2012
Abstract A62: Combination of BXL-0124, a vitamin D analog and LG100268 for the prevention of ER-negative breast cancer
Background: ER-positive Breast cancer prevention is now possible using antiestrogen drugs; however, this treatment is ineffective… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)